We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Photoacoustic Technology May Revolutionize Cancer Research

By LabMedica International staff writers
Posted on 13 Apr 2011
Print article
Innovative technology that combines the sensitivity of optical imaging with the resolution and depth penetration of high-frequency ultrasound will enable researchers to study cancer in its earliest stages of progression and evaluate tumor growth and the effect that potential drugs have on that growth.

The VisualSonics Inc. (Toronto, Canada) Vevo LAZR uses a laser to shoot pulses of light through the skin into tissue and cells beneath the surface. The absorbed laser energy is then converted into heat, producing an ultrasonic emission, which can be captured and turned into images using a specially adapted high frequency ultrasonic probe. VisualSonics is a wholly owned subsidiary of SonoSite Inc. (Seattle, WA, USA).

The key to this novel approach is the capability of a wide range of biological materials to absorb laser light. Specific tissue components including oxyhemoglobin, deoxyhemoglobin, melanin, and lipids all absorb laser energy, which is then converted into heat that produces an ultrasonic emission that can be captured and turned into images using a specially adapted high frequency ultrasonic probe.

Applications for the Vevo LAZR system range from lymph node imaging to the study of hemoglobin and oxygen saturation and the targeted imaging of tumor biomarkers. In addition to cancer biology, this innovative technology will benefit other areas of life science research such as diabetes, neurosciences, and developmental and reproductive biology.

"The Vevo LAZR photoacoustics system is a breakthrough in vivo imaging technology,” said Anil Amlani president and CEO of VisualSonics. "Advancements featured in this product will enable oncology researchers to accelerate their research into understanding of the inner workings of the cancerous cell and the host tissue in which it resides. The ability to conduct this microscopic level research in a living organism, noninvasively and in real time will help our customers to turn groundbreaking science into lifesaving care, at an even greater speed.”

"We believe that the Vevo LAZR system will have a strong impact on the discovery of new cancer therapies, more efficient testing of therapies with never-before-seen insights into cancer, and quantified measures of cancer progression, viewed from inside the tumor,” said Kevin M. Goodwin, president and CEO of SonoSite. "With the launch of Vevo LAZR technology, we continue to meet our commitment to our customers by providing imaging technologies needed to further tomorrow's research today.”

Related Links:

VisualSonics Inc.
SonoSite Inc.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.